update management postoperative nausea vomiting pubmed ncbi abstract antiemetic drug developments formulations guidelines risk evaluation controversies occurred area postoperative nausea vomiting ponv developments helped improve understanding prevention treatment ponv postanesthesia care unit discharge home hospital ward antiemetic drug research resulted introduction second-generation num hydroxytryptamine num ht num receptor antagonist palonosetron neurokinin num nk num receptor antagonist aprepitant data existing antiemetics frontier nausea vomiting research therapy area postdischarge nausea vomiting patient discharged home phase ii ambulatory stepdown unit hospital ward antiemetic drug selection depends efficacy cost safety ease dosing safety concerns arisen side effects antiemetics specifically effect ecg prolongation qtc interval butyrophenones first-generation num ht num receptor antagonist class antiemetics impact pharmocogenetics antiemetic drug metabolism resulting efficacy correlated genetic makeup affecting drug response discussion ethics ponv research initiated meta-analysis ponv studies guide antiemetic selection ponv therapy clinical practitioners society ambulatory anesthesia samba ponv consensus guidelines introduced updated 
